Poly Medicure Ltd.
BSE: 531768 | Sector: Health care |
NSE: POLYMED | ISIN Code: INE205C01021 |
BSE 00:00 | 23 Mar | 964.10 |
-5.75 (-0.59%) |
OPEN
975.30 |
HIGH
978.95 |
LOW
953.05 |
NSE 00:00 | 23 Mar | 963.35 |
-5.40 (-0.56%) |
OPEN
966.05 |
HIGH
978.95 |
LOW
950.25 |
OPEN | 975.30 |
PREVIOUS CLOSE | 969.85 |
VOLUME | 2682 |
52-Week high | 1044.40 |
52-Week low | 652.30 |
P/E | 57.83 |
Mkt Cap.(Rs cr) | 9,253 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Poly Medicure Ltd. (POLYMED) - Net Profit
Net Profit
COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
Cipla | 869.50 | 6.10 | 0.71 | 2957.93 |
Divi's Lab. | 2801.05 | 11.05 | 0.40 | 2948.54 |
Glenmark Pharma. | 436.70 | 0.35 | 0.08 | 1997.79 |
Glaxosmi. Pharma | 1294.15 | 12.45 | 0.97 | 1690.53 |
Dr Reddy's Labs | 4447.95 | -28.05 | -0.63 | 1623.20 |
Alkem Lab | 3148.90 | -65.30 | -2.03 | 1541.25 |
Aurobindo Pharma | 486.15 | 7.05 | 1.47 | 1454.71 |
Gland Pharma | 1294.65 | 49.65 | 3.99 | 1212.16 |
Torrent Pharma. | 1531.20 | 12.25 | 0.81 | 991.45 |
Sanofi India | 5680.70 | -17.85 | -0.31 | 944.40 |
Ipca Labs. | 784.85 | 2.80 | 0.36 | 870.94 |
Zydus Lifesci. | 482.35 | 3.80 | 0.79 | 857.90 |
Abbott India | 21550.15 | 77.30 | 0.36 | 798.70 |
Laurus Labs | 303.05 | -2.15 | -0.70 | 750.09 |
Ajanta Pharma | 1230.80 | 12.25 | 1.01 | 719.86 |
Apollo Hospitals | 4271.10 | -8.25 | -0.19 | 665.20 |
Pfizer | 3515.75 | -15.20 | -0.43 | 612.56 |
Suven Pharma | 471.40 | -0.45 | -0.10 | 558.10 |
Alembic Pharma | 488.95 | -7.10 | -1.43 | 543.55 |
Glenmark Life | 413.30 | -1.80 | -0.43 | 418.72 |
Quick Links for Poly Medicure:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices